Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
355.4 INR | -0.95% | -30.71% | -13.20% |
04-26 | Aster DM Healthcare Names CFO | MT |
04-25 | Aster DM Healthcare Limited Announces Resignation of Amitabh Johri as A Key Managerial Personnel | CI |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Sales forecast by analysts have been recently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With an expected P/E ratio at 42.98 and 24.36 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.20% | 2.14B | - | ||
-20.16% | 16.21B | B+ | ||
+4.50% | 12.44B | B | ||
+3.98% | 11.58B | B+ | ||
+4.63% | 10.79B | B+ | ||
-0.21% | 7.68B | A- | ||
+18.43% | 7.06B | D | ||
+4.49% | 6.67B | B- | ||
+50.89% | 4.66B | - | ||
-5.12% | 4.25B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ASTERDM Stock
- Ratings Aster DM Healthcare Limited